Triple
T4784984
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | mAb114 |
E106453
|
entity |
| Predicate | clinicalTrialEvidence |
P23163
|
FINISHED |
| Object | PALM trial in the Democratic Republic of the Congo |
—
|
LITERAL FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: PALM trial in the Democratic Republic of the Congo | Statement: [mAb114, clinicalTrialEvidence, PALM trial in the Democratic Republic of the Congo]
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: clinicalTrialEvidence Context triple: [mAb114, clinicalTrialEvidence, PALM trial in the Democratic Republic of the Congo]
-
A.
coordinatesClinicalTrialsFor
Indicates that one entity organizes, manages, or oversees the planning and execution of clinical trials on behalf of another entity.
-
B.
hasKeyClinicalTrial
chosen
Indicates that an entity is associated with a primary or pivotal clinical trial that is especially important for its evaluation or approval.
-
C.
trialDesign
Indicates the specific structure, methodology, and procedural plan according to which a trial or experiment is conducted.
-
D.
hasScientificStudy
Indicates that there exists a scientific study that investigates, analyzes, or provides evidence about the referenced entity or relationship.
-
E.
sponsorInKeyTrials
Indicates that an entity serves as a sponsor in one or more key clinical or experimental trials involving another entity.
- F. None of above.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69bd43f4a9588190bf73e20bc27c03cc |
completed | March 20, 2026, 12:56 p.m. |
| NER | Named-entity recognition | batch_69bd65ae49ec81908f16248d22d1155f |
completed | March 20, 2026, 3:20 p.m. |
| PD | Predicate disambiguation | batch_69bd622e1b408190806c15c61519fc74 |
completed | March 20, 2026, 3:05 p.m. |
Created at: March 20, 2026, 1:22 p.m.